Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Jupiter Life Line Hospitals Ltd (JLHL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543980 NSE: JLHL Hospital & Healthcare Services | Small Cap | Jupiter Life Line Share Price
₹277.90 1.90 (0.69%)
As on 22-Sep'26 12:13
Jupiter Life Line Hospitals Ltd (JLHL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543980 NSE: JLHL Hospital & Healthcare Services | Small Cap | Jupiter Life Line Share Price
₹277.90 1.90 (0.69%)
As on 22-Sep'26 12:13
Key Metrics
Valuation Multiples
Market Cap
₹9,048 Cr.
Current Price
₹277.9
52-Week Low / High
₹230 / 338
TTM EPS
₹5.7
TTM Sales
₹1,558 Cr.
Book Value per Share
₹48.2
P/E Ratio
48.23
Lower than its 5-year historical median
Industry PE
101.7
Price to Book (P/B)
5.72
Lower than its 5-year historical median
Price to Sales (P/S)
5.81
Lower than its 5-year historical median
EV/EBITDA
24.72
Lower than its 5-year historical median
Dividend Yield
0.07%
Profitability Efficiency
Return on Equity (ROE)
13.39%
Outperforms industry median
Return on Capital Employed (ROCE)
15.70%
In line with industry median
Return on Assets (ROA)
9.07%
Operating Profit Margin
22.9%
Net Profit Margin
12.95%
Gross Profit Margin
23.5%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
12.98%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
13.75%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
0.23%
Asset Quality
Promoter Holding
40.91%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹1,516 Cr.
Equity
₹65.6 Cr.
Face Value
₹2
All Time Low / High
₹192.00 / 351.80
Check Before You Invest
Quality
Somewhat GoodValuation
FairCheck Valuation charts
Price Trend
Weak
Is Jupiter Life Line Hospitals Ltd a good quality company?
Jupiter Life Line Hospitals Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Jupiter Life Line Hospitals Ltd performance compare with that of its Peers?
Revenue growth of Jupiter Life Line Hospitals Ltd vs industry peers?
Jupiter Life Line Hospitals Ltd revenue CAGR is 25.27%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Jupiter Life Line Hospitals Ltd?
Promoters hold 40.91% of the Jupiter Life Line Hospitals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Jupiter Life Line Hospitals Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 9.02% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Jupiter Life Line Hospitals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 17.2% | 10.4% | 10% | 12.1% | 9% | 23.2% | 26.4% | 22.2% | 18.6% | 16% | - |
| Value Creation Index ⓘ | 0.3 | -0.2 | -0.3 | -0.1 | -0.3 | 0.7 | 1.0 | 0.6 | 0.4 | 0.2 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 264 | 320 | 399 | 463 | 461 | 657 | 787 | 915 | 1,060 | 1,198 | 1,248 |
| Sales YoY Gr. | - | 21.3% | 24.4% | 16.2% | -0.4% | 42.6% | 19.8% | 16.2% | 15.9% | 13% | - |
| Adj EPS ⓘ | 1.2 | 1.2 | 0.7 | 1.2 | 0.7 | 3.3 | 3.8 | 4.6 | 5.6 | 5.7 | 5.7 |
| YoY Gr. | - | 1.7% | -39.8% | 63.4% | -44% | 410.8% | 15.7% | 20.8% | 20.5% | 1.8% | - |
| BVPS (₹) ⓘ | 6.7 | 7.8 | 8.4 | 9.3 | 10 | 12.9 | 16.5 | 38 | 43.4 | 49 | 50.2 |
| Adj Net Profit ⓘ | 29.3 | 29.9 | 18.1 | 29.6 | 16.6 | 84.5 | 109 | 152 | 183 | 187 | 185 |
| Cash Flow from Ops. ⓘ | 62.7 | 43.5 | 45.6 | 74.6 | 113 | 142 | 184 | 110 | 219 | 231 | - |
| Debt/CF from Ops. ⓘ | 3 | 4.8 | 5.5 | 3.5 | 2.3 | 2.3 | 1.6 | 0 | 0.3 | 1.1 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 18.3% | 21% | 15% | 13% | ||||
| Adj EPS ⓘ | 19.3% | 54.3% | 14% | 1.8% | ||||
| BVPSⓘ | 24.7% | 37.6% | 43.9% | 13% | ||||
| Share Price | - | - | 9.3% | -5.4% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 18.9 | 16.2 | 8.8 | 13.2 | 6.8 | 29 | 27.4 | 17.8 | 13.8 | 12.3 | 11.4 |
| Op. Profit Mgn % ⓘ | 23.3 | 17 | 16.3 | 17.6 | 14.6 | 24.2 | 25.9 | 24.9 | 25.7 | 25.1 | 24.2 |
| Net Profit Mgn % ⓘ | 11.1 | 9.3 | 4.5 | 6.4 | 3.6 | 12.9 | 13.8 | 16.6 | 17.3 | 15.6 | 14.8 |
| Debt to Equity ⓘ | 1.1 | 1.1 | 1.2 | 1.1 | 1 | 1 | 0.6 | 0 | 0.1 | 0.2 | - |
| Working Cap Days ⓘ | 50 | 54 | 65 | 88 | 91 | 54 | 62 | 115 | 97 | 69 | 97 |
| Cash Conv. Cycle ⓘ | -42 | -41 | -28 | -29 | -36 | -35 | -32 | -23 | -15 | -14 | 74 |
Valuation of Jupiter Life Line - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|
| Sales | 463 | 486 | 733 | 893 | 1,073 | 1,302 | 1,500 |
| Operating Expenses ⓘ + | 380 | 419 | 580 | 691 | 831 | 1,002 | 1,158 |
| Operating Profit ⓘ | 83 | 67 | 153 | 201 | 242 | 300 | 341 |
| Operating Profit Margin (%) | 17.8% | 13.8% | 20.9% | 22.6% | 22.6% | 23.0% | 22.8% |
| Other Income ⓘ + | 2 | 4 | 4 | 10 | 22 | 28 | 44 |
| Interest ⓘ | 26 | 39 | 44 | 42 | 26 | 11 | 33 |
| Depreciation ⓘ | 26 | 31 | 36 | 39 | 42 | 57 | 88 |
| Profit Before Tax ⓘ | 33 | 2 | 77 | 129 | 195 | 261 | 260 |
| Tax ⓘ | 3 | 4 | 26 | 56 | 19 | 67 | 66 |
| Profit After Tax | 30 | -2 | 51 | 73 | 177 | 194 | 194 |
| PAT Margin (%) | 6.4% | -0.5% | 7.0% | 8.2% | 16.5% | 14.9% | 13.0% |
| Adjusted EPS (₹) | 1.2 | -0.1 | 2.0 | 2.6 | 5.4 | 5.9 | 5.9 |
| Dividend Payout Ratio (%) | 0% | 0% | 10% | 7.80% | 3.70% | 3.40% | 3.40% |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 237 | 239 | 292 | 366 | 1,169 | 1,356 | 1,544 | ||||
| Debt + | 263 | 413 | 488 | 457 | 0 | 322 | 501 | ||||
| Minority Interest | 0 | 7 | -5 | -2 | -0 | 0 | 0 | ||||
| Trade Payables | 59 | 59 | 61 | 71 | 62 | 69 | 96 | ||||
| Others Liabilities ⓘ | 44 | 70 | 73 | 94 | 50 | 169 | 223 | ||||
| Total Liabilities ⓘ | 603 | 789 | 909 | 986 | 1,281 | 1,917 | 2,363 | ||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 435 | 630 | 684 | 720 | 718 | 978 | 1,384 | ||||
| CWIP ⓘ | 11 | 26 | 27 | 29 | 74 | 185 | 129 | ||||
| Investments ⓘ | 2 | 7 | 3 | 2 | 17 | 507 | 486 | ||||
| Inventories | 14 | 13 | 15 | 19 | 21 | 26 | 38 | ||||
| Trade Receivables | 45 | 22 | 28 | 46 | 57 | 43 | 76 | ||||
| Cash Equivalents | 7 | 19 | 103 | 134 | 301 | 95 | 58 | ||||
| Others Assets ⓘ | 90 | 71 | 49 | 36 | 93 | 82 | 192 | ||||
| Total Assets ⓘ | 603 | 789 | 909 | 986 | 1,281 | 1,917 | 2,363 | ||||
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 74 | 123 | 137 | 117 | 115 | 267 | 268 |
| Cash Flow From Investing Activity ⓘ + | -43 | -296 | -85 | -104 | -246 | -497 | -442 |
| Cash Flow From Financing Activity ⓘ + | -32 | 185 | 33 | 18 | 128 | 297 | 136 |
| Net Cash Flow ⓘ | -1 | 12 | 85 | 31 | -3 | 66 | -38 |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 12.52 | -0.97 | 19.27 | 22.18 | 23.02 | 15.35 | 13.39 | |||
| ROCE (%) | 11.52 | 6.91 | 16.66 | 21.07 | 22.14 | 19.04 | 15.7 | |||
| Asset Turnover Ratio | 0.77 | 0.7 | 0.86 | 0.94 | 0.95 | 0.81 | 0.7 | |||
| PAT to CFO Conversion(x) | 2.47 | N/A | 2.69 | 1.6 | 0.65 | 1.38 | 1.38 | |||
| Working Capital Days | ||||||||||
| Receivable Days | 35.20 | 25 | 12.40 | 15 | 17.50 | 14.10 | 14.50 | |||
| Inventory Days | 11 | 10.10 | 7.10 | 7 | 6.90 | 6.70 | 7.90 | |||
| Payable Days | 267.80 | 217.20 | 153.60 | 153.10 | 128.10 | 93.80 | 104.60 | |||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Jupiter Life Line Hospitals Ltd FAQs
The current trading price of Jupiter Life Line on 22-Sep-2026 12:13 is ₹277.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Sep-2026 the market cap of Jupiter Life Line stood at ₹9,048.1 Cr
The latest P/E ratio of Jupiter Life Line as of 21-Sep-2026 is 48.84.
The latest P/B ratio of Jupiter Life Line as of 21-Sep-2026 is 5.50.
The 52-week high of Jupiter Life Line is ₹337.9 and the 52-week low is ₹230.4.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jupiter Life Line is ₹1,248 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Jupiter Life Line Hospitals Ltd is a average quality company.
The key valuation ratios of Jupiter Life Line Hospitals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Jupiter Life Line Hospitals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Jupiter Life Line Hospitals Ltd
Jupiter Life Line Hospitals was incorporated in Mumbai, Maharashtra, as ‘Jupiter Life Line Hospitals Limited’, a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2002, issued by the RoC. The company commenced its business on December 24, 2002. The company is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area (MMR) and western region of India. It has been operating for many years as a corporate quaternary care healthcare service provider in densely populated micro markets in the western regions of India and currently operate three hospitals under the ‘Jupiter’ brand in Thane, Pune and Indore. It is also currently in the process of developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate many beds.
The company commenced operations in 2007 with its hospital in Thane, Maharashtra and subsequently scaled its operations by setting up a hospital in Pune, Maharashtra in 2017 and acquiring a hospital in Indore, Madhya Pradesh in 2020. Its hospitals are also located in densely populated micro markets which have a low presence of chained hospitals, which provides it an opportunity to offer its services to a larger population and helps its patients with greater access and connectivity to healthcare services. Its hospitals function on an ‘all-hub-no-spoke’ model with each hospital being a full-service hospital, operating independently and serving the healthcare needs of patients, right from diagnostics to surgery and rehabilitation. Its Thane and Pune hospitals are ‘greenfield’ projects, and all three of its hospitals are located on land owned by it on a freehold basis, which ensures operational control and allows it consistency in quality care resulting in long-term operational and financial efficiencies.
Business area of the company
The company is engaged in the business of operating and managing hospitals and clinics in India. The company is among the key multi-specialty tertiary and quaternary healthcare providers.
Awards
- 2018: Awarded the Best Multispecialty hospital in Thane District at the NavBharat Healthcare Excellence Awards.
- 2019: Awarded the Hospital of the year - India at the Healthcare Asia Awards.
- 2019: Awarded for outstanding contribution in charitable healthcare at the Star of the Industry Awards.
- 2019: Received the award for best design in healthcare for its Indore Hospital, at the Healthcare Leadership Awards.
- 2021: Recognized for excellence in change management for its Thane Hospital at the CHRO Vision & Innovation Summit and Awards.
- 2021: Winner of the award for excellence in workplace management for the human resources department of its Thane Hospital at the CHRO Vision & Innovation Summit and Awards.
- 2021: Received the Silver award - Covid Protection Project at the IHW Awards.
- 2022: Received the NEERMAN award in the healthcare category for its Pune Hospital.
- 2022: Received the milestone merits 2022 - safety award from the IMC Ramkrishna Bajaj National Quality Trust.
- 2023: Awarded the certificate of excellence for its Indore Hospital for being the cleanest hospital in Indore at the Swachh Ward Rankings.
- 2023: Awarded the Maharashtra state best employer brand award, 2023 at the 18th Employer Branding Awards.
Accreditations and recognitions
- 2020: Accreditation for its Thane Hospital by the National Accreditation Board for Hospital & Healthcare Providers.
- 2020: Accreditation for its Pune Hospital, Maharashtra by the National Accreditation Board for Hospital & Healthcare Providers.
- 2021: Accreditation for its Indore Hospital, Madhya Pradesh by the National Accreditation Board for Hospital & Healthcare Providers.
- 2022: ISO 15189:2012 accreditation for the department of laboratory medicine of its Pune Hospital by the National Accreditation Board for Testing and Calibration Laboratories.
- 2022: ISO 15189:2012 accreditation for the department of laboratory medicine of its Thane Hospital by the National Accreditation Board for Testing and Calibration Laboratories.
- 2023: ISO 22000:2018 accreditation for food safety and management system for the Fortune Park Lake City hotel at Thane by the Standards Council of Canada.
History and milestones
- 2007: Established and commenced operations of its first hospital at Thane, Maharashtra.
- 2017: Established and commenced operations of its Pune Hospital.
- 2018: Carried out interstitial brachytherapy to treat cancer at its Thane Hospital.
- 2020: Acquired its Indore Hospital.
- 2021: Successfully carried out small bowel intestine transplant surgery at its Thane, Hospital.
- 2022: Successfully carried out heart transplant surgery at its Thane Hospital.
You have 46 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
